Evidence map›Paper›PMID 32235610›Full record

ReviewInternational journal of molecular sciences2020

The Current Understanding of Autophagy in Nanomaterial Toxicity and Its Implementation in Safety Assessment-Related Alternative Testing Strategies.

Rong-Jane Chen, Yu-Ying Chen, Mei-Yi Liao, Yu-Hsuan Lee, Zi-Yu Chen, Shian-Jang Yan, Ya-Ling Yeh, Li-Xing Yang, Yen-Ling Lee, Yuan-Hua Wu and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. TiJournal of nanobiotechnology · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Challenges to Safe Nanomedicine Treatment.Nanomaterials (Basel, Switzerland) · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Chronic effects of two rutile TiOParticle and fibre toxicology · 2022
    Article
  16. Maternal exposure to CeOJournal of nanobiotechnology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Rong-Jane ChenDepartment of Food Safety/Hygiene and Risk Management, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Yu-Ying ChenDepartment of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Mei-Yi LiaoDepartment of Applied Chemistry, National Pingtung University, Pingtung 900, Taiwan.
Yu-Hsuan LeeDepartment of Cosmeceutics, China Medical University, Taichung 651, Taiwan.
Zi-Yu ChenDepartment of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Shian-Jang YanDepartment of Physiology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
Ya-Ling YehDepartment of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Li-Xing YangInstitute of Oral Medicine and Department of Stomatology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan 701, Taiwan.
Yen-Ling LeeDepartment of Hematology/Oncology, Tainan Hospital of Health and Welfare, Tainan 700, Taiwan.
Yuan-Hua WuDepartment of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Ying-Jan WangDepartment of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.ORCID 0000-0003-3169-2495
National Cheng Kung University · TWChina Medical University · TWNational Cheng Kung University Hospital · TWNational Pingtung University · TW

Funding

Environmental Protection Administration, Executive Yuan, R.O.C. Taiwan 107A024Ministry of Science and Technology, Taiwan MOST 106-2314-B-006-029-MY3Ministry of Science and Technology, Taiwan MOST 107-2311-B-006-004-MY3Ministry of Science and Technology, Taiwan MOST 108-2113-M-153-001Ministry of Science and Technology, Taiwan MOST 108-2314-B-006-057
6 · The paper itself

Abstract

Nanotechnology has rapidly promoted the development of a new generation of industrial and commercial products; however, it has also raised some concerns about human health and safety. To evaluate the toxicity of the great diversity of nanomaterials (NMs) in the traditional manner, a tremendous number of safety assessments and a very large number of animals would be required. For this reason, it is necessary to consider the use of alternative testing strategies or methods that reduce, refine, or replace (3Rs) the use of animals for assessing the toxicity of NMs. Autophagy is considered an early indicator of NM interactions with cells and has been recently recognized as an important form of cell death in nanoparticle-induced toxicity. Impairment of autophagy is related to the accelerated pathogenesis of diseases. By using mechanism-based high-throughput screening in vitro, we can predict the NMs that may lead to the generation of disease outcomes in vivo. Thus, a tiered testing strategy is suggested that includes a set of standardized assays in relevant human cell lines followed by critical validation studies carried out in animals or whole organism models such as

Indexed as

AutophagyAnimalsHigh-Throughput Screening AssaysHumansNanostructuresToxicity Testsalternative testing strategyautophagyC. eleganshigh throughput screeningnanomaterialstiered testing strategyzebrafish and Drosophila models

Identifiers

PMID32235610
PMCPMC7177614
OpenAlexW3013304012

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.